Invitation to Potential Sponsors & Exhibitors
KSVIRUS 2019 is offering a broad range of excellent opportunities for you to partner, so that you can highlight your brand and products to a targeted audience of 150-175 investigators who do research on oncogenic DNA viruses to foster new collaborations and ways of thinking about Kaposi’s sarcoma virus and to explore new therapeutic strategies for treating patients with ailments associated with this oncogenic virus. We are devoted to help you with maximizing your visibility at this annual international event.
Human viruses are associated with ~17% of human cancers. EBV, KSHV, and HPVs infect a large percentage of humans by adulthood and play complex co-factor roles in a variety of malignancies. These include Kaposi’s sarcoma, primary effusion lymphoma, and multicentric Castleman’s disease for KSHV. These cancers are elevated in HIV-AIDS and other forms of immunosuppression, including treatments for organ transplantation. Several therapeutic approaches have been explored, including vaccination. However, KSHV is a complex virus with >90 open reading frames, as well as a number of non-coding RNAs. Some of these viral factors have been characterized and we understand some of their contributions to pathogenesis, but research studies continue to shed light on the complexity of this virus, warranting an annual meeting. In addition, mortality as a result of KS, PEL and MCD continues to be high (by some measures over 50%), especially in developing countries. Thus, additional preventive interventions, vaccines and anti-viral therapies to achieve protection from KSHV and other agents, ideally specifically targeting virally induced oncogenic mechanisms, are needed for these virus-associated malignancies. Development of these therapeutic modalities requires a deep understanding of basic mechanisms of pathogenesis, which are provided by related animal viruses (i.e. MHV68, RRV, HVS) that allow for in vivo studies in a natural host.
The KSHV meeting originated soon after the discovery of KSHV in 1994 as the causal agent of KS, PEL and MCD. Some of the first scientific presentations on this virus were on the Conference on AIDS Related Kaposi’s Sarcoma sponsored by the NCI. The first KSHV Workshop was held in 1998 at UC-Santa Cruz. Meetings have been held annually since then, largely rotating among the US west coast, US east coast, and Europe. The 2019 meeting marks the 25th anniversary of the discovery of KSHV by Drs. Patrick Moore and Yuan Chang at Columbia University in New York City, and the selection of this city was intentional to commemorate this event. Co-Chair, Dr. Cesarman, also participated on that discovery (Chang, Cesarman, et al, Science 266:1865, 1994).
Sponsor & Exhibitor Opportunities Include:
Please note that all exhibition and sponsorship opportunities will be allocated on a 1st come, 1st served basis.
- Tabletop Exhibit with one participant badge: $1500, with two badges, $2,000
- Session Sponsorship recognition: $2,000
- Name badge lanyards with company logo: $500 (company to provide the logo)
- Name badge sponsorship: $1,000, includes name badge printing (full-color), plastic holders and company logo on the back of the name badges with a mini program-at-a-glance
- One page ad in the Final Program & Abstract Books: $1,500
- Student/Postdoc Travel Awards: $1,500 – $5,000
- Sponsor of the Welcome Reception on the Rooftop patio at the NY Marriott East Side, $5,000
- Sponsor of the Final Night Networking Dinner, exclusive group dinner on the World Yacht Duchess Dinner Cruise on the Hudson, $10,000
For further information, please contact: Joan Oefner, Conference Manager, at joefner ( @ ) societymanagement.com